| CANDRIAM EQUITIES L BIOTECHNOLOGY C-H CAP EUR | RVI BIOTECNOLOGÍA | 27,22% | 68,93% | 49,46% | 117,20% |
| INVESCO JAPANESE EQUITY ADVANTAGE A CAP EUR | RVI JAPÓN | 27,22% | 46,75% | 34,08% | · |
| UBS (LUX) EQUITY SICAV - GLOBAL HIGH DIVIDEND (USD) (EUR HEDGED) Q-ACC | RVI GLOBAL VALOR | 27,22% | 70,69% | 70,53% | 120,95% |
| POLAR CAPITAL HEALTHCARE DISCOVERY I USD CAP | RVI SALUD | 27,21% | 36,03% | 7,21% | · |
| BNY MELLON GLOBAL EMERGING MARKETS OPPORTUNITIES FUND GBP (ACC) GBP | RVI EMERGENTES | 27,20% | 56,24% | 26,66% | 130,41% |
| COBAS INTERNACIONAL, FI B | RVI GLOBAL VALOR | 27,20% | 95,96% | · | · |
| STATE STREET SPDR S&P 500 UCITS ETF MXN HEDGED ACC | RVI USA | 27,20% | · | · | · |
| NINETY ONE GSF ASIAN EQUITY FUND A ACC EUR HEDGED | RVI ASIA EX-JAPÓN | 27,19% | 100,29% | 45,71% | · |
| OFI INVEST ISR ACTIONS JAPON RF | RVI JAPÓN | 27,19% | · | · | · |
| SANTANDER AM LATIN AMERICAN EQUITY OPPORTUNITIES AE CAP | RVI LATINOAMÉRICA | 27,19% | 37,49% | 56,49% | · |
| INVESCO JAPANESE EQUITY ADVANTAGE A CAP USD | RVI JAPÓN | 27,18% | · | · | · |
| ROBECO QI GLOBAL MOMENTUM EQUITIES D EUR | RVI GLOBAL | 27,18% | 92,21% | 84,47% | 203,71% |
| UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) (USD HEDGED) Q-ACC | RVI EUROPA | 27,18% | 41,23% | 53,00% | 169,22% |
| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO I (SNAP) EUR CAP | RVI JAPÓN | 27,17% | 62,21% | · | · |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO A (CLOSE) USD DIS | RVI USA SMALL/MID CAP | 27,17% | 73,35% | 58,19% | 165,61% |
| ABN AMRO BOSTON COMMON US SUSTAINABLE EQUITIES A USD CAP | RVI USA | 27,16% | 51,09% | 48,57% | · |
| BGF US FLEXIBLE EQUITY C2 USD | RVI USA | 27,16% | 73,53% | 86,72% | 252,08% |
| CAPITAL GROUP JAPAN EQUITY FUND (LUX) B EUR | RVI JAPÓN | 27,16% | 51,94% | 33,56% | 107,93% |
| CAPITAL GROUP NEW WORLD FUND (LUX) A7 USD | RVI EMERGENTES | 27,16% | 68,92% | 52,24% | · |
| JPM JAPAN SUSTAINABLE EQUITY A (ACC) JPY | RVI JAPÓN | 27,15% | 65,54% | 41,87% | 110,77% |
